smartcybers786@gmail.com 
A woman holds a small bottle labelled with a "Vaccine Covid-19" sticker and a medical syringe in this illustration taken April 10, 2020. — Reuters
#Covid19 #cases #surge #Pakistan #global #spike
ISLAMABAD: The World Health Organization (WHO) said Wednesday that the highest level in the eastern Mediterranean region, the virus test rate increased by 17 % in April 2025.
Although in early May 2025, it dropped slightly to 15 %, with the spike surpassing last year’s level, identifying a significant restoration of Sir Co -2 in the country.
Whose surveillance data from the sanitary sites shows that Pakistan, Egypt, Kuwait, Oman, Saudi Arabia and the United Arab Emirates are facing 19 circulation.
Due to the limited reporting of hospitalization, ICU’s admission and deaths, the World Health Agency has also flagged the country, making it difficult to evaluate the actual burden on the health care system.
During the rising transmission, officials at Aga Khan University Hospital in Karachi have confirmed that at least four people have been killed in the last two weeks. All four were immunocomized and had the main health conditions, including diabetes, cancer, or cardiovascular disease.
They were enrolled with complications related to Covade and could not survive despite deep care.
Globally, COVID-19 activity has also increased. Since mid -February, the positiveness rate of the test has increased from 2 % to 11 % in 73 reporting countries, which has not been observed since July 2024.
The most important increase is being reported from the East Mediterranean, Southeast Asia, and the Western Pacific. While the African region, Europe and the United States are reporting less positive levels, some sub -areas such as the Caribbean and the Andes are beginning to show up the trends above. Waste water surveillance data from Europe and North America currently identify low SARS -2 activity.
Which has also raised concerns over a new “various types of surveillance”, NB.1.8.1, which is now 10.7 % of the global report, which is more than 2.5 % just four weeks ago.
Different types of JN.1 is a child of the lineage and raises spike protein mutuality associated with increasing transmitting and lacking antibody.
While it has not yet been reported from Pakistan for NB.1.8.1, which notes that these three regions are increasing various forms with dynamic genomic continuity: the Western Pacific, the United States and Europe.
Vaccination is critical, yet the increase in high -risk groups is low worldwide. From January to September 2024, only 1.68 percent of older adults and 0.96 percent healthcare workers in the reporting countries received the Kovade 19 vaccine dose. In the lower and middle -income countries, with significantly low rates, the US and Europe recorded a high amount of increase.
Which has urged high -risk groups to immediately vaccinate, and suggest that any available vaccine is better than delays in safety vaccines while waiting for formulations of various forms.
Countries have adopted various strategies since the official collapse of the International concern in May 2023, since the official collapse of the Public Health Emergency.
Some have integrated the Code 19 into the current respiratory disease control system, while others live in the transition. However, financial obstacles, shortage of manpower, and competitive health priorities are hindering long -term preparations in many countries.
Despite the lower deaths and hospitals in hospitals, which still rate the risk of Quaid -19 globally. The main reason for this is due to unexpectedly variable evolution, seasonal deficiency and ongoing circulation. Who emphasizes that the current dominant variations, LP.8.1 and NB.1.8.1, do not appear to be the cause of more severe illness than the previous tension, but guarantee close surveillance.
Countries are encouraged to evaluate genomic surveillance, cennal testing, and the effects and effects of diseases. Who also reminds member states that its International Health Regulations (IHR) Standing recommendations are correct during April 2026 and should guide the National Covid-19 policies. Currently, no travel or trade restrictions are advised.
As part of the long -term threat management, who said it was helping countries through the latest strategic framework, technical guidance, and harmony. The purpose of these projects is to embed the Cavade 19 control in extensive efforts to prepare for respiratory diseases, to ensure that countries are ready to manage the risk of seasonal influenza and other respiratory pathogens, as well as future corona virus risks.
